Background: The incidence of prostate cancer in Cameroon has been in creasing in an alarming rate. The aim of this study is to characterize the form of prostate cancer and associated factors in patients from Cameroon Northern Regions. Methods: All patients with positive prostate biopsy (cancer+) from June 2018 to November 2019 were studied (n = 177). The followings were retrieved: digital rectal examination, standard clinical examinations, laboratory data such as serum prostate-specific antigen (PSA) level, and the Gleason score. Patients self-administered a questionnaire assessing prostate cancer’s risk factors. Results: Patients were mainly from the Far North region (36.72%), and were either farmers or breeders (48.01%). Only prostate adenocarcinoma was present, with predominance of aggressive forms (Gleason score ≥ 7). Significant relationships were observed between Gleason score and 1) patients’ age (P = 0.006), 2) history of urinary tract infections (P = 0.015) and of exposure to agricultural products (P = 0.049), 3) clinical signs (nycturia, pollakiuria, poor acute urine retention, and dysuria) (P = 0.019), 4 ) prostate weight, and 5 ) serum PSA levels (P < 0.0001). Conclusion: Aggressive forms of adenocarcinoma are the main prostate cancer in these regions, underlining the need for strategies aimed at raising prostate cancer awareness and early detection.
Cassell, A., Yunusa, B., Jalloh, M., Mbodji, M.M., Diallo, A., Ndoye, M., et al. (2019) A Review of Localized Prostate Cancer: An African Perspective. World Journal of Oncology, 10, 162-168. https://doi.org/10.14740/wjon1221
Morhason-Bello, I.O., Odedina, F., Rebbeck, T.R., Harford, J., Dangou, J.-M., Denny, L. and Adewole, I.F. (2013) Challenges and Opportunities in Cancer Control in Africa: A Perspective from the African Organisation for Research and Training in Cancer. The Lancet Oncology, 14, e142-e151. https://doi.org/10.1016/S1470-2045(12)70482-5
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., Znaor, A. and Bray, F. (2019) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953. https://doi.org/10.1002/ijc.31937
de Koning, H.J., Liem, M.K., Baan, C.A., Boer, R., Schröder, F.H. and Alexander, F.E. (2002) Prostate Cancer Mortality Reduction by Screening: Power and Time Frame with Complete Enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) Trial. International Journal of Cancer, 98, 268-273. https://doi.org/10.1002/ijc.10188
Kaninjing, E., Lopez, I., Nguyen, J., Odedina, F. and Young, M.E. (2018) Prostate Cancer Screening Perception, Beliefs, and Practices among Men in Bamenda, Cameroon. American Journal of Men’s Health, 12, 1463-1472. https://doi.org/10.1177%2F1557988318768596
Batty, G.D., Kivimäki, M., Clarke, R., Davey Smith, G. and Shipley, M.J. (2011) Modifiable Risk Factors for Prostate Cancer Mortality in London: Forty Years of Follow-up in the Whitehall Study. Cancer Causes & Control, 22, 311-318. https://doi.org/10.1007/s10552-010-9691-6
Harrison, S., Tilling, K., Turner, E.L., Martin, R.M., Lennon, R., Lane, J.A., Donovan, J.L., Hamdy, F.C., Neal, D.E., Bosch, J.L.H.R. and Jones, H.E. (2020) Systematic Review and Meta-Analysis of the Associations between Body Mass Index, Prostate Cancer, Advanced Prostate Cancer, and Prostate-Specific Antigen. Cancer Causes & Control, 31, 431-449. https://doi.org/10.1007/s10552-020-01291-3
Skinner, H.G. and Schwartz, G.G. (2008) Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiology, Biomarkers & Prevention, 17, 2302-2305. https://doi.org/10.1158/1055-9965.EPI-08-0365
Stocks, T., Hergens, M.-P., Englund, A., Ye, W. and Stattin, P. (2010) Blood Pressure, Body Size and Prostate Cancer Risk in the Swedish Construction Workers Cohort. International Journal of Cancer, 127, 1660-1668. https://doi.org/10.1002/ijc.25171
Li, J., Djenaba, J.A., Soman, A., Rim, S.H. and Master, V.A. (2012) Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001-2007. Prostate Cancer, 2012, Article ID: 691380. https://doi.org/10.1155/2012/691380
Angwafo, F.F., Atanga, P.N., Minkoulou, E., Fouda, P.J., Kim, K.S., Adams-Campbell, L. and Zoung-Kanyi, J. (2003) Factors Influencing Patient Survival in a Group of Men with Prostate Cancer in Yaoundé, Cameroon. UroOncology, 3, 7-11. https://doi.org/10.1080/1561095031000101269
Engbang, J., Sala, B., Moby, H., Ligan, Y., Djimeli, B., Simo, G., Moune, A., Mouelle, A., Fewou, A., Essame, J. and Hasigov, A. (2017) Epidemiomorphology of Prostate Cancer in Cameroon: About 1047 Cases. Journal of Cancer and Tumor International, 6, 1-8. https://doi.org/10.9734/JCTI/2017/37565
Enow Orock, G.E. and Doh, A.S. (2012) Current Cancer Incidence and Trends in Yaounde, Cameroon. Oncology, Gastroenterology and Hepatology Reports, 1, 58-63. http://doi.org/10.5530/ogh.2012.1.14
Jennifer, R.S., Sven, P., Meir, J.S., Jennifer, A.S., Stephen, F., Anna, S.E., et al. (2009) Gleason Score and Lethal Prostate Cancer: Does 3+4=4+3? Journal of Clinical Oncology, 27, 3459-3464. https://doi.org/10.1200/JCO.2008.20.4669
Kumar, N.B., Yu, D., Akinremi, T.O. and Odedina, F.T. (2009) Comparing Dietary and Other Lifestyle Factors among Immigrant Nigerian Men Living in the US and Indigenous Men from Nigeria: Potential Implications for Prostate Cancer Risk Reduction. Journal of Immigrant and Minority Health, 11, 391-399. https://doi.org/10.1007/s10903-009-9231-1
Discacciati, A., Orsini, N., Andersson, S.-O., Andrén, O., Johansson, J.-E. and Wolk, A. (2011) Body Mass Index in Early and Middle-Late Adulthood and Risk of Localised, Advanced and Fatal Prostate Cancer: A Population-Based Prospective Study. British Journal of Cancer, 105, 1061-1068. https://doi.org/10.1038/bjc.2011.319
Shafique, K., McLoone, P., Qureshi, K., Leung, H., Hart, C. and Morrison, D.S. (2012) Cholesterol and the Risk of Grade-Specific Prostate Cancer Incidence: Evidence from Two Large Prospective Cohort Studies with Up to 37 Years’ Follow up. BMC Cancer, 12, Article No. 25. https://doi.org/10.1186/1471-2407-12-25
Guyton, K.Z., Loomis, D., Grosse, Y., El Ghissassi, F., Benbrahim-Tallaa, L., Guha, N., Scoccianti, C., Mattock, H. and Straif, K. (2015) International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France, 2015. Carcinogenicity of Tetrachlorvinphos, Parathion, Malathion, Diazinon, and Glyphosate. Lancet Oncology, 16, 490-491. https://doi.org/10.1016/S1470-2045(15)70134-8
Levêque-Morlais, N., Tual, S., Clin, B., Adjemian, A., Baldi, I. and Lebailly, P. (2015) The AGRIculture and CANcer (AGRICAN) Cohort Study: Enrollment and Causes of Death for the 2005-2009 Period. International Archives of Occupational and Environmental Health, 88, 61-73. https://doi.org/10.1007/s00420-014-0933-x
Giovannucci, E., Liu, Y., Stampfer, M.J. and Willett, W.C. (2006) A Prospective Study of Calcium Intake and Incident and Fatal Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention, 15, 203-210. https://doi.org/10.1158/1055-9965.EPI-05-0586
Tate, P.L., Bibb, R. and Larcom, L.L. (2011) Milk Stimulates Growth of Prostate Cancer Cells in Culture. Nutrition and Cancer, 63, 1361-1366. https://doi.org/10.1080/01635581.2011.609306
Vento, S. (2013) Cancer Control in Africa: Which Priorities? The Lancet Oncology, 14, 277-279. https://doi.org/10.1016/S1470-2045(13)70022-6
Visalini, N., Sarsha, Y., Carlos, N., Sam, E., Jennifer, R., Manish, P., Dianne, L.O.C., Freddy, S., Bruce, K.A. and David, P.S. (2017) Adult Body Size, Sexual History and Adolescent Sexual Development, May Predict Risk of Developing Prostate Cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR). International Journal of Cancer, 140, 565-574. https://doi.org/10.1002/ijc.30471
Papa, N.P., MacInnis, R.J., English, D.R., Bolton, D., Davis, I.D., Lawrentschuk, N., Millar, J.L., Pedersen, J., Severi, G., Southey, M.C., Hopper, J.L. and Giles, G.G. (2017) Ejaculatory Frequency and the Risk of Aggressive Prostate Cancer: Findings from a Case-Control Study. Urologic Oncology: Seminars and Original Investigations, 35, 530.e7-530.e13. https://doi.org/10.1016/j.urolonc.2017.03.007
Rider, J.R., Wilson, K.M., Sinnott, J.A., Kelly, R.S., Mucci, L.A. and Giovannucci, E.L. (2016) Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. European Urology, 70, 974-982. https://doi.org/10.1016/j.eururo.2016.03.027
Jian, Z., Ye, D., Chen, Y., Li, H. and Wang, K. (2018) Sexual Activity and Risk of Prostate Cancer: A Dose-Response Meta-Analysis. The Journal of Sexual Medicine, 15, 1300-1309. https://doi.org/10.1016/j.jsxm.2018.07.004
Fan, C.-Y., Huang, W.-Y., Lin, K.-T., Lin, C.-S., Chao, H.-L., Yang, J.-F., Lin, C.-L. and Kao, C.-H. (2017) Lower Urinary Tract Infection and Subsequent Risk of Prostate Cancer: A Nationwide Population-Based Cohort Study. PLoS ONE, 12, e0168254. https://doi.org/10.1371/journal.pone.0168254
Papa, N.P., MacInnis, R.J., English, D.R., Bolton, D., Davis, I.D., Lawrentschuk, N., Millar, J.L., Severi, G., Hopper, J.L. and Giles, G.G. (2018) Early-Onset Baldness and the Risk of Aggressive Prostate Cancer: Findings from a Case-Control Study. Cancer Causes & Control, 29, 93-102. https://doi.org/10.1007/s10552-017-0981-0